Cue Biopharma Stock Technical Analysis
| CUE Stock | USD 1.07 0.05 4.46% |
As of the 17th of October 2024, Cue Biopharma shows the risk adjusted performance of 0.0618, and Mean Deviation of 6.89. Cue Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cue Biopharma potential upside, skewness, as well as the relationship between the jensen alpha and coefficient of variation to decide if Cue Biopharma is priced correctly, providing market reflects its regular price of 1.07 per share. Given that Cue Biopharma is a hitting penny stock territory we recommend to closely look at its total risk alpha.
Cue Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cue, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CueCue |
Cue Biopharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 10.0 | Strong Buy | 5 | Odds |
Most Cue analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cue stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cue Biopharma, talking to its executives and customers, or listening to Cue conference calls.
Cue Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cue Biopharma Technical Analysis
The output start index for this execution was five with a total number of output elements of fifty-six. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cue Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Cue Biopharma Trend Analysis
Use this graph to draw trend lines for Cue Biopharma. You can use it to identify possible trend reversals for Cue Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cue Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Cue Biopharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Cue Biopharma applied against its price change over selected period. The best fit line has a slop of 0.01 , which may imply that Cue Biopharma will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 1.14, which is the sum of squared deviations for the predicted Cue Biopharma price change compared to its average price change.About Cue Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cue Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cue Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cue Biopharma price pattern first instead of the macroeconomic environment surrounding Cue Biopharma. By analyzing Cue Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cue Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cue Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 76.77 | 16.78 | 112.89 | 99.03 | PTB Ratio | 5.4 | 1.55 | 3.26 | 3.09 |
Cue Biopharma October 17, 2024 Technical Indicators
Most technical analysis of Cue help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cue from various momentum indicators to cycle indicators. When you analyze Cue charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0618 | |||
| Market Risk Adjusted Performance | 0.5687 | |||
| Mean Deviation | 6.89 | |||
| Semi Deviation | 5.37 | |||
| Downside Deviation | 6.09 | |||
| Coefficient Of Variation | 1539.03 | |||
| Standard Deviation | 10.7 | |||
| Variance | 114.56 | |||
| Information Ratio | 0.0575 | |||
| Jensen Alpha | 0.5998 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.1011 | |||
| Treynor Ratio | 0.5587 | |||
| Maximum Drawdown | 62.62 | |||
| Value At Risk | (8.43) | |||
| Potential Upside | 18.46 | |||
| Downside Variance | 37.11 | |||
| Semi Variance | 28.8 | |||
| Expected Short fall | (11.53) | |||
| Skewness | 2.67 | |||
| Kurtosis | 9.33 |
Complementary Tools for Cue Stock analysis
When running Cue Biopharma's price analysis, check to measure Cue Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cue Biopharma is operating at the current time. Most of Cue Biopharma's value examination focuses on studying past and present price action to predict the probability of Cue Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cue Biopharma's price. Additionally, you may evaluate how the addition of Cue Biopharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |